• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算感染变异 alpha(VOC 202012/01)的 COVID-19 病例:2021 年 1 月至 3 月在东京的筛查数据分析。

Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.

机构信息

School of Medicine, International University of Health and Welfare, Kozunomori 4-3, Narita City, Chiba, 286-8686, Japan.

Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

出版信息

Theor Biol Med Model. 2021 Jul 17;18(1):13. doi: 10.1186/s12976-021-00146-x.

DOI:10.1186/s12976-021-00146-x
PMID:34273991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8286039/
Abstract

BACKGROUND

In Japan, a part of confirmed patients' samples have been screened for the variant of concern (VOC), including the variant alpha with N501Y mutation. The present study aimed to estimate the actual number of cases with variant alpha and reconstruct the epidemiological dynamics.

METHODS

The number of cases with variant alpha out of all PCR confirmed cases was estimated, employing a hypergeometric distribution. An exponential growth model was fitted to the growth data of variant alpha cases over fourteen weeks in Tokyo.

RESULTS

The weekly incidence with variant alpha from 18-24 January 2021 was estimated at 4.2 (95% confidence interval (CI): 0.7, 44.0) cases. The expected incidence in early May ranged from 420-1120 cases per week, and the reproduction number of variant alpha was on the order of 1.5 even under the restriction of contact from January-March, 2021, Tokyo.

CONCLUSIONS

The variant alpha was predicted to swiftly dominate COVID-19 cases in Tokyo, and this has actually occurred by May 2021. Devising the proposed method, any country or location can interpret the virological sampling data.

摘要

背景

在日本,已对部分确诊患者样本进行了变体关注(VOC)筛查,包括带有 N501Y 突变的变体 alpha。本研究旨在估计实际的变体 alpha 病例数并重建流行病学动态。

方法

利用超几何分布估计所有 PCR 确诊病例中变体 alpha 的病例数。对东京 14 周内变体 alpha 病例的增长数据拟合指数增长模型。

结果

2021 年 1 月 18 日至 24 日,变体 alpha 的每周发病率估计为 4.2(95%置信区间(CI):0.7,44.0)例。预计 5 月初每周的病例数为 420-1120 例,即使在 2021 年 1 月至 3 月限制接触的情况下,变体 alpha 的繁殖数也在 1.5 左右。

结论

预计变体 alpha 将迅速在东京主导 COVID-19 病例,而实际上到 2021 年 5 月已经发生了这种情况。通过提出的方法,任何国家或地区都可以解释病毒学采样数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2875/8286603/266b9df09049/12976_2021_146_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2875/8286603/9285801c79c9/12976_2021_146_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2875/8286603/266b9df09049/12976_2021_146_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2875/8286603/9285801c79c9/12976_2021_146_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2875/8286603/266b9df09049/12976_2021_146_Fig2_HTML.jpg

相似文献

1
Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.估算感染变异 alpha(VOC 202012/01)的 COVID-19 病例:2021 年 1 月至 3 月在东京的筛查数据分析。
Theor Biol Med Model. 2021 Jul 17;18(1):13. doi: 10.1186/s12976-021-00146-x.
2
Estimating the transmissibility of SARS-CoV-2 VOC 202012/01 in Japan using travel history information.利用旅行史信息估计日本 SARS-CoV-2 VOC 202012/01 的传染性。
Math Biosci Eng. 2022 Jan 12;19(3):2750-2761. doi: 10.3934/mbe.2022125.
3
Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.预测 SARS-CoV-2 变异株德尔塔在 2021 年 7 月日本东京奥运会前的主导地位。
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.
4
Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan.日本变异株阿尔法导致的 COVID-19 年龄相关风险。
Front Public Health. 2022 Jun 10;10:837970. doi: 10.3389/fpubh.2022.837970. eCollection 2022.
5
Trends in COVID-19 Outbreak in Tokyo and Osaka from January 25 to May 6, 2020: a Joinpoint Regression Analysis of the Outbreak Data.2020年1月25日至5月6日东京和大阪新冠肺炎疫情趋势:疫情数据的Joinpoint回归分析
Jpn J Infect Dis. 2021 Jan 22;74(1):73-75. doi: 10.7883/yoken.JJID.2020.332. Epub 2020 Jun 30.
6
Not all fun and games: Potential incidence of SARS-CoV-2 infections during the Tokyo 2020 Olympic Games.并非全是娱乐:2020年东京奥运会期间新型冠状病毒感染的潜在发生率。
Math Biosci Eng. 2021 Nov 4;18(6):9685-9696. doi: 10.3934/mbe.2021474.
7
Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?应对东京奥运会期间的 COVID-19:我们是否正确评估了风险?
Epidemics. 2022 Sep;40:100618. doi: 10.1016/j.epidem.2022.100618. Epub 2022 Jul 27.
8
Transmissibility of asymptomatic COVID-19: Data from Japanese clusters.无症状 COVID-19 的传染性:来自日本集群的数据。
Int J Infect Dis. 2021 Apr;105:236-238. doi: 10.1016/j.ijid.2021.02.065. Epub 2021 Feb 19.
9
Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.利用接触者追踪数据探索无症状病例的 SARS-CoV-2 二次传播。
Theor Biol Med Model. 2021 Jul 16;18(1):12. doi: 10.1186/s12976-021-00144-z.
10
Increased Transmissibility of the SARS-CoV-2 Alpha Variant in a Japanese Population.在日本人群中,SARS-CoV-2 阿尔法变异株的传染性增强。
Int J Environ Res Public Health. 2021 Jul 22;18(15):7752. doi: 10.3390/ijerph18157752.

引用本文的文献

1
Time series forecasting of COVID-19 infections and deaths in Alpha and Delta variants using LSTM networks.使用 LSTM 网络对 Alpha 和 Delta 变体的 COVID-19 感染和死亡进行时间序列预测。
PLoS One. 2023 Oct 20;18(10):e0282624. doi: 10.1371/journal.pone.0282624. eCollection 2023.
2
Assessing Public Health and Social Measures Against COVID-19 in Japan From March to June 2021.评估2021年3月至6月日本针对新冠疫情采取的公共卫生及社会措施。
Front Med (Lausanne). 2022 Jul 12;9:937732. doi: 10.3389/fmed.2022.937732. eCollection 2022.
3
Impact of the Coming-of-Age Day and ceremony on the risk of SARS-CoV-2 transmission in Japan: A natural-experimental study based on national surveillance data.

本文引用的文献

1
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England.2020 年英格兰 SARS-CoV-2 疫情的关键流行病学驱动因素和干预措施的影响。
Sci Transl Med. 2021 Jul 14;13(602). doi: 10.1126/scitranslmed.abg4262. Epub 2021 Jun 22.
2
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.量化 N501Y 取代 SARS-CoV-2 在英国的传播优势:一项早期基于数据的分析。
J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taab011.
3
Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study.
成年礼和仪式对日本 SARS-CoV-2 传播风险的影响:基于全国监测数据的自然实验研究。
Influenza Other Respir Viruses. 2022 Nov;16(6):1026-1032. doi: 10.1111/irv.13027. Epub 2022 Jul 27.
4
Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan.年龄对 COVID-19 疫苗和医疗负担对 COVID-19 死亡的影响,日本东京。
Emerg Infect Dis. 2022 Sep;28(9):1777-1784. doi: 10.3201/eid2809.220377. Epub 2022 Jul 12.
5
Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study.考虑奥密克戎变异株的韩国 COVID-19 疫情的多方面分析:基于数学模型的研究。
J Korean Med Sci. 2022 Jul 4;37(26):e209. doi: 10.3346/jkms.2022.37.e209.
6
Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan.日本变异株阿尔法导致的 COVID-19 年龄相关风险。
Front Public Health. 2022 Jun 10;10:837970. doi: 10.3389/fpubh.2022.837970. eCollection 2022.
7
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.日本大规模的 COVID-19 血清学监测:获得针对 Delta 的中和抗体,但未获得针对奥密克戎的中和抗体,需要加强接种以克服奥密克戎的爆发。
PLoS One. 2022 Apr 5;17(4):e0266270. doi: 10.1371/journal.pone.0266270. eCollection 2022.
8
Nonlinear frequency analysis of COVID-19 spread in Tokyo using empirical mode decomposition.利用经验模态分解分析东京地区 COVID-19 传播的非线性频率。
Sci Rep. 2022 Feb 9;12(1):2175. doi: 10.1038/s41598-022-06095-w.
9
The impact of temperature on the transmissibility potential and virulence of COVID-19 in Tokyo, Japan.温度对日本东京地区 COVID-19 的传播潜力和毒力的影响。
Sci Rep. 2021 Dec 29;11(1):24477. doi: 10.1038/s41598-021-04242-3.
10
The global transmission of new coronavirus variants.新型冠状病毒变体的全球传播。
Environ Res. 2022 Apr 15;206:112240. doi: 10.1016/j.envres.2021.112240. Epub 2021 Oct 22.
利用多事件研究估计非药物干预对 COVID-19 发病率和人口流动模式的全球影响。
Sci Rep. 2021 Jan 21;11(1):1972. doi: 10.1038/s41598-021-81442-x.
4
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.2020 年 10 月至 11 月英国 SARS-CoV-2 N501Y 突变株的早期传播能力评估。
Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
5
Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.传播动力学揭示了 COVID-19 群体免疫策略不切实际。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25897-25903. doi: 10.1073/pnas.2008087117. Epub 2020 Sep 22.
6
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.
7
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.利用 2020 年 2 月钻石公主号游轮上疫情的年龄调整后数据估计冠状病毒病(COVID-19)的感染和病死率。
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.2000256.
8
Serial interval of novel coronavirus (COVID-19) infections.新型冠状病毒(COVID-19)感染的连续间隔。
Int J Infect Dis. 2020 Apr;93:284-286. doi: 10.1016/j.ijid.2020.02.060. Epub 2020 Mar 4.
9
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).新型冠状病毒肺炎(COVID-19)死亡风险的传达
J Clin Med. 2020 Feb 21;9(2):580. doi: 10.3390/jcm9020580.
10
Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases.新型冠状病毒(COVID-19)感染死亡风险的实时估计:基于输出病例的推断
J Clin Med. 2020 Feb 14;9(2):523. doi: 10.3390/jcm9020523.